RTGN
RetinalGenix Technologies Inc.Company Information
- Company Name
- RetinalGenix Technologies Inc.
- CIK
- CIK0001836295
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- RTGN: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- RTGN
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- 0.00%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | ||||||
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | ||||||
| Property Plant And Equipment Net | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | ||||||
| Security Deposit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | ||||||
| Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 3 | 3 | 2 | 2 | 2 | 2 | 1 | 2 | - | - | 1 | - | ||||||
| Notes Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | ||||||
| Interest Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | ||||||
| Liabilities | 3 | 3 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 1 | 1 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 16 | 16 | 16 | 15 | 15 | 14 | 14 | 13 | 12 | 12 | 10 | 9 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | -3 | -3 | -2 | -2 | -2 | -2 | -1 | -2 | -2 | -2 | -1 | -1 | ||||||
| Stockholders Equity Note Subscriptions Receivable | - | - | -0 | - | - | - | -0 | - | - | - | - | - | ||||||
| Retained Earnings Accumulated Deficit | -19 | -18 | -18 | -17 | -17 | -16 | -15 | -15 | -14 | -13 | -11 | -11 | ||||||
| Liabilities And Stockholders Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | ||||||
| Common Stock Shares Issued | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 18 | 18 | 18 | 18 | 18 | ||||||
| Shares Outstanding | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 18 | 18 | 18 | 18 | 18 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialRetinalGenix Technologies Inc. (RTGN) — SEC Financial Statements & Analysis
RetinalGenix Technologies Inc. (RTGN) is a surgical & medical instruments & apparatus company, incorporated in DE. RetinalGenix Technologies Inc. trades on OTC as: RTGN. RetinalGenix Technologies Inc. (RTGN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, RetinalGenix Technologies Inc. carries a market cap of $75.23M, a P/E ratio of -36.00x, a P/B ratio of -28.49x, an enterprise value of $75.25M, and an EV/EBITDA multiple of -36.14x. On profitability, it posts a Return on Equity (ROE) of 90.43% and a Return on Assets (ROA) of -10293.84%. Per share, it reports EPS of $-0.11, diluted EPS of $-0.11, free cash flow per share of $-0.03, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -23.95% year-over-year and EPS growth of -25.90% year-over-year. On the balance sheet, it maintains a current ratio of 0.01x, a quick ratio of 0.01x, working capital of $-2.64M, a debt-to-equity ratio of -1.01x, a debt ratio of 82.97, an interest coverage ratio of -287.61x, free cash flow of $-477.94K (TTM), and net debt of $21.77K. Figures sourced from SEC EDGAR.
- Market Cap
- $75.23M
- P/E TTM
- -36.00x
- EPS TTM
- $-0.11
- P/B TTM
- -28.49x
- ROE TTM
- 90.43%
- ROA TTM
- -10293.84%
- Debt To Equity
- -1.01x
- Free Cash Flow TTM
- $-477.94K
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is RetinalGenix Technologies Inc. in?
RetinalGenix Technologies Inc. (RTGN) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does RTGN trade on?
RetinalGenix Technologies Inc. (RTGN) trades on the OTC.
Where is RetinalGenix Technologies Inc. incorporated?
RetinalGenix Technologies Inc. is incorporated in DE.
When was RetinalGenix Technologies Inc. (RTGN)'s most recent SEC filing?
RetinalGenix Technologies Inc. (RTGN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is RTGN's market cap?
RetinalGenix Technologies Inc. (RTGN) has a market capitalization of $75.23M as of 2026-06-30.
What is RTGN's EPS (earnings per share)?
RetinalGenix Technologies Inc. (RTGN)'s trailing twelve month EPS is $-0.11 as of 2026-06-30.
What is RTGN's ROE (return on equity)?
RetinalGenix Technologies Inc. (RTGN)'s trailing twelve month Return on Equity (ROE) is 90.43% as of 2026-06-30.
What is RTGN's ROA (return on assets)?
RetinalGenix Technologies Inc. (RTGN)'s trailing twelve month Return on Assets (ROA) is -10293.84% as of 2026-06-30.
What is RTGN's EV/EBITDA?
RetinalGenix Technologies Inc. (RTGN)'s trailing twelve month EV/EBITDA is -36.14x as of 2026-06-30.